Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias

Francis J. Giles, Stefan Faderl, Deborah A. Thomas, Jorge E. Cortes, Guillermo Garcia-Manero, Dan Douer, Alexandra M. Levine, Charles A. Koller, Sima S. Jeha, Susan M. O'Brien, Elihu H. Estey, Hagop M. Kantarjian

Research output: Contribution to journal › Article › peer-review